A Phase Ib study to assess safety, tolerability, pharmacokinetics, and preliminary antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors

Jeffrey Goh, Ben Gao, Ben Markman, Hui Gan, Mark Voskoboynik, Yi-Long Wu, Jun Guo, Qing Zhou, Jun Zhao, Cheng Chen, Jingjun Qiu, Yingying Xu, Liu Yang, Michael Millward

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages2
JournalCancer Research
Issue number13
Publication statusPublished - Jul 2019
EventAnnual Meeting of the American-Association-for-Cancer-Research (AACR) - Atlanta, United States
Duration: 29 Mar 20193 Apr 2019

Cite this